Cargando…

Effects of baseline symptom burden on treatment response in COPD

RATIONALE: In symptomatic patients with COPD, the decision whether to initiate maintenance treatment with a single agent or a combination of long-acting bronchodilators remains unclear. OBJECTIVE: To investigate whether baseline symptomatic status influences response to tiotropium/olodaterol treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez, Fernando J, Abrahams, Roger A, Ferguson, Gary T, Bjermer, Leif, Grönke, Lars, Voß, Florian, Singh, Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324615/ https://www.ncbi.nlm.nih.gov/pubmed/30655665 http://dx.doi.org/10.2147/COPD.S179912

Ejemplares similares

Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
por: Singh, Dave, et al.
Publicado: (2016)

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
por: Ferguson, Gary T., et al.
Publicado: (2017)

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO(®) and OTEMTO(®) studies: a subgroup analysis by age
por: Ferguson, Gary T, et al.
Publicado: (2016)

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
por: Rabe, Klaus F., et al.
Publicado: (2020)

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)
por: Buhl, Roland, et al.
Publicado: (2015)

Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis
por: Ferguson, Gary T., et al.
Publicado: (2015)

Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial
por: Vogelmeier, Claus F., et al.
Publicado: (2020)

Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO(®) and OTEMTO(®) Studies
por: Buhl, Roland, et al.
Publicado: (2020)

Predictive modeling of COPD exacerbation rates using baseline risk factors
por: Singh, Dave, et al.
Publicado: (2022)

Bronchodilator response of advanced lung function parameters depending on COPD severity
por: Jarenbäck, Linnea, et al.
Publicado: (2016)

The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies
por: Ichinose, Masakazu, et al.
Publicado: (2016)

The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)
por: Beeh, Kai-Michael, et al.
Publicado: (2016)

Understanding the impact of symptoms on the burden of COPD
por: Miravitlles, Marc, et al.
Publicado: (2017)

Altered fibroblast proteoglycan production in COPD
por: Hallgren, Oskar, et al.
Publicado: (2010)

Flow-Volume Parameters in COPD Related to Extended Measurements of Lung Volume, Diffusion, and Resistance
por: Jarenbäck, Linnea, et al.
Publicado: (2013)

Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients
por: Menzel, Mandy, et al.
Publicado: (2016)

Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
por: Mackay, Alexander J., et al.
Publicado: (2020)

The Efficiency Index (EFFi), based on volumetric capnography, may allow for simple diagnosis and grading of COPD
por: Jarenbäck, Linnea, et al.
Publicado: (2018)

To live a life with COPD – the consequences of symptom burden
por: Johansson, Helena, et al.
Publicado: (2019)

Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study)
por: Roche, Nicolas, et al.
Publicado: (2020)

Small airway epithelial-C/EBPβ is increased in patients with advanced COPD
por: Mori, Michiko, et al.
Publicado: (2015)

A new approach to assess COPD by identifying lung function break-points
por: Eriksson, Göran, et al.
Publicado: (2015)

Economic burden of COPD in a Swedish cohort: the ARCTIC study
por: Lisspers, Karin, et al.
Publicado: (2018)

Asthma symptoms, mannitol reactivity and exercise-induced bronchoconstriction in adolescent swimmers versus tennis players
por: Romberg, Kerstin, et al.
Publicado: (2017)

Inflammation and chronic colonization of Haemophilus influenzae in sputum in COPD patients related to the degree of emphysema and bronchiectasis in high-resolution computed tomography
por: Tufvesson, Ellen, et al.
Publicado: (2017)

Do patients and carers agree on symptom burden in advanced COPD?
por: Mi, Emma, et al.
Publicado: (2018)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease
por: Øie, Marte Rystad, et al.
Publicado: (2022)

Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients
por: Ställberg, Björn, et al.
Publicado: (2018)

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
por: Kerwin, Edward M, et al.
Publicado: (2020)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers
por: Bajc, Marika, et al.
Publicado: (2014)

The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used
por: Jögi, Jonas, et al.
Publicado: (2014)

Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD
por: Jarenbäck, Linnea, et al.
Publicado: (2022)

Oxidative Stress Attenuates TLR3 Responsiveness and Impairs Anti-viral Mechanisms in Bronchial Epithelial Cells From COPD and Asthma Patients
por: Menzel, Mandy, et al.
Publicado: (2019)

Burden of COPD in Nepal
por: Adhikari, Tara Ballav, et al.
Publicado: (2018)

Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study
por: Ferguson, Gary T, et al.
Publicado: (2020)

Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population
por: Bjermer, Leif, et al.
Publicado: (2017)

Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD
por: Slok, Annerika H M, et al.
Publicado: (2014)

Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD
por: Tufvesson, Ellen, et al.
Publicado: (2020)

Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts
por: Larsson-Callerfelt, Anna-Karin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7eroq42r5bv60eelijnm9fgri1